GSK to appeal Delaware court ruling in Zantac litigation
Court ruling appeal process beginsGSK 'strongly' disagrees with prior rulingShares weighed down by litigation worriesGSK (GSK) confirmed it has taken steps to appeal a Delaware judge's decision (31 May) to allow 70,000 cases to go to trial and present expert testimony in ongoing litigation claims that its discontinued heartburn drug Zantac caused cancer.The company said it 'strongly' disagrees wit